Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First Critical Reality Check First Your legal team's "6 months" likely refers to a full label revision, not initial safety signal reporting. FDA requires serious unexpected adverse events reported within 15 days (7 days if fatal).Read the full answer
This is a crisis scenario that defines a CEO's legacy. The decision matrix is clear: Patient safety and regulatory compliance must supersede short-term financial protection. Hiding this information constitutes securities fraud and potential criminal negligence (precedents include Vioxx/Merck and Purdue Pharma).Read the full answer